289 related articles for article (PubMed ID: 22072221)
1. Why mammography screening has not lived up to expectations from the randomised trials.
Gøtzsche PC; Jørgensen KJ; Zahl PH; Mæhlen J
Cancer Causes Control; 2012 Jan; 23(1):15-21. PubMed ID: 22072221
[TBL] [Abstract][Full Text] [Related]
2. Mammography screening: A major issue in medicine.
Autier P; Boniol M
Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
[TBL] [Abstract][Full Text] [Related]
3. Benefits and harms of mammography screening.
Løberg M; Lousdal ML; Bretthauer M; Kalager M
Breast Cancer Res; 2015 May; 17(1):63. PubMed ID: 25928287
[TBL] [Abstract][Full Text] [Related]
4. Quality-of-life effects of screening mammography in Norway.
Zahl PH; Kalager M; Suhrke P; Nord E
Int J Cancer; 2020 Apr; 146(8):2104-2112. PubMed ID: 31254388
[TBL] [Abstract][Full Text] [Related]
5. Overdiagnosis and overtreatment of breast cancer: estimates of overdiagnosis from two trials of mammographic screening for breast cancer.
Duffy SW; Agbaje O; Tabar L; Vitak B; Bjurstam N; Björneld L; Myles JP; Warwick J
Breast Cancer Res; 2005; 7(6):258-65. PubMed ID: 16457701
[TBL] [Abstract][Full Text] [Related]
6. Screening and prevention of breast cancer in primary care.
Tice JA; Kerlikowske K
Prim Care; 2009 Sep; 36(3):533-58. PubMed ID: 19616154
[TBL] [Abstract][Full Text] [Related]
7. Screening mammography--early detection or over-diagnosis? Contribution from Australian data.
Bell RJ
Climacteric; 2014 Dec; 17 Suppl 2():66-72. PubMed ID: 25224048
[TBL] [Abstract][Full Text] [Related]
8. Pan-Canadian study of mammography screening and mortality from breast cancer.
Coldman A; Phillips N; Wilson C; Decker K; Chiarelli AM; Brisson J; Zhang B; Payne J; Doyle G; Ahmad R
J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25274578
[TBL] [Abstract][Full Text] [Related]
9. The balance sheet of benefits and harms of breast cancer population-based screening in Europe: outcome research, practice and future challenges.
Broeders M; Paci E
Womens Health (Lond); 2015 Nov; 11(6):883-90. PubMed ID: 26619214
[TBL] [Abstract][Full Text] [Related]
10. Overdiagnosis and overtreatment of breast cancer: overdiagnosis in randomised controlled trials of breast cancer screening.
Moss S
Breast Cancer Res; 2005; 7(5):230-4. PubMed ID: 16168145
[TBL] [Abstract][Full Text] [Related]
11. The other side of technology: risk of overdiagnosis of breast cancer with mammography screening.
Puliti D; Paci E
Future Oncol; 2009 May; 5(4):481-91. PubMed ID: 19450177
[TBL] [Abstract][Full Text] [Related]
12. Mammographic screening for breast cancer. Overdiagnosis: an insidious adverse effect of screening.
Prescrire Int; 2015 Jul; 24(162):186-9, 191. PubMed ID: 26240891
[TBL] [Abstract][Full Text] [Related]
13. Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer.
Ringash J;
CMAJ; 2001 Feb; 164(4):469-76. PubMed ID: 11233866
[TBL] [Abstract][Full Text] [Related]
14. Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study.
Ciatto S; Houssami N; Bernardi D; Caumo F; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Montemezzi S; Macaskill P
Lancet Oncol; 2013 Jun; 14(7):583-9. PubMed ID: 23623721
[TBL] [Abstract][Full Text] [Related]
15. Controversies in Screening Mammography.
Swain M; Jeudy M; Pearlman MD
Clin Obstet Gynecol; 2016 Jun; 59(2):351-61. PubMed ID: 27101240
[TBL] [Abstract][Full Text] [Related]
16. A systematic assessment of benefits and risks to guide breast cancer screening decisions.
Pace LE; Keating NL
JAMA; 2014 Apr; 311(13):1327-35. PubMed ID: 24691608
[TBL] [Abstract][Full Text] [Related]
17. Opportunity for breast cancer screening in limited resource countries: a literature review and implications for Iran.
Asadzadeh VF; Broeders MJ; Kiemeney LA; Verbeek AL
Asian Pac J Cancer Prev; 2011; 12(10):2467-75. PubMed ID: 22320940
[TBL] [Abstract][Full Text] [Related]
18. Missteps in Current Estimates of Cancer Overdiagnosis.
Lee CI; Etzioni R
Acad Radiol; 2017 Feb; 24(2):226-229. PubMed ID: 27894707
[TBL] [Abstract][Full Text] [Related]
19. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years.
Miller AB; Baines CJ; To T; Wall C
CMAJ; 1992 Nov; 147(10):1477-88. PubMed ID: 1423088
[TBL] [Abstract][Full Text] [Related]
20. Delayed diagnosis of breast cancer in women recalled for suspicious screening mammography.
Duijm LE; Groenewoud JH; de Koning HJ; Coebergh JW; van Beek M; Hooijen MJ; van de Poll-Franse LV
Eur J Cancer; 2009 Mar; 45(5):774-81. PubMed ID: 19046632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
